A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Clinical trial NCT01904253 · TERMINATED

Trial details

NCT number: NCT01904253
Sponsor: Taiho Oncology, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer (SCLC)

Start date: 2013-07-01
Primary completion: 2014-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.